Tel: 1-631-626-9181 (USA)    44-207-097-1828 (Europe)


Official Full Name
B-cell CLL/lymphoma 9
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]
BCL9; B-cell CLL/lymphoma 9; LGS; B-cell CLL/lymphoma 9 protein; bcl-9; protein legless homolog; B-cell lymphoma 9 protein; MGC131591; si:ch73-15j19.1; B-cell lymphoma 9; nuclear co-factor of beta-catenin signalling

Interested in learning more?

Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.

Request a quote today!